Page 64 - Demo

BUSINESS
CANCER VACCINE MARKET TO
TRIPLE
The cancer vaccines market will almost triple from $2.5 billion in 2015 to $7.5 billion by 2022, with compound annual growth of 16.93%, according to business intelligence provider GBI Research.
The company’s latest report found that therapeutic vaccines, a type of immunotherapy, that have a lower toxicity than traditional chemotherapies, would increase the overall survival of poor-performance-status patients, and enable more rounds of treatments to be given, thus driving market growth.
Associate Analyst for GBI Research Adam Bradbury said the ‘cancer vaccines space’ would see impressive growth over next decade
for a number of reasons. There was a
fairly large cancer vaccine pipeline,
with more than 1,200 products being developed, accounting for almost 17%
of the overall oncology pipeline, the
largest of any therapy area.
ˆ L to R: Taylor Maher and Rachael Stewart (Make-A-Wish); Phil Smith, CEO, Blooms The Chemist; Gerard Menses, and Tessa Barrat (Make-A-Wish).
MAKE A WISH WITH BLOOMS
Blooms The Chemist has partnered with Make-A-Wish Australia, to help make the wishes of seriously ill children come true.
Over the next year, the banner group will donate a percentage of its retail profits to Make-A-Wish, a significant funding boost to the children’s charity.
Since 1985, Make-A-Wish has brought hope, strength and joy to very sick kids and teens across Australia. Make-A-Wish CEO, Gerard Menses, said: ‘Every day, six families around Australia receive the news that their child
has a life-threatening medical condition. That’s 2,000 families each year in need of a vital wish; four times the number of families we’re currently able to reach. Thanks to this new partnership we’ll be able to grant even more wishes than ever before. We’re absolutely delighted to have Blooms as a part of our wish force.’
SIGMA AND FRED IT PARTNER ON CLOUD-BASED
RETAIL PLATFORM
Sigma Pharmaceuticals and Fred IT Group have joined forces to deliver Sigma’s next generation retail platform that will support more than 700 pharmacies across Australia.
The platform is a single cloud based technology solution to underpin Sigma’s broader technology and data strategy implementation. The announcement follows an extensive evaluation process of IT systems,
and will enable Sigma to provide support to its brand members – Amcal, Guardian, Discount Drug Stores, PharmaSave and Chemist King. The program is built on Fred IT’s integrated pharmacy cloud solution, Fred NXT.
Sigma CEO and Managing Director Mark Hooper said the combination of Sigma’s industry knowledge and Fred’s IT credentials ticked all the boxes.
‘Sigma now has the largest branded pharmacy footprint in Australia with over 700 pharmacies delivering almost 20% share of the pharmacy retail sales market. So having a solution that is agile, has full connectivity into retail pharmacy, and supports our growth is critical. It strengthens our market position and also provides opportunities to explore extensions of our partnership with Fred IT and the Telstra Health team.’
62 Australian Pharmacist January 2017 I ©Pharmaceutical Society of Australia Ltd.
SELF CARE PHARMACIES IN
POTY FINALS
Two Self Care pharmacies are among the six finalists in the Guild Pharmacy of the Year Awards.
They are Capital Chemist Southlands and Capital Chemist Wanniassa, both Australian Capital Territory. The awards recognise excellence in pharmacy
across three categories – Business Management, Community Engagement, and Professional Services Innovation.
The judging group said all six finalists had recognised the need for change and had embraced that need. The other finalists are: Lucy Walker Chemmart Goondiwindi, Queensland, Waikerie Chemplus, South Australia, Terry White Chemmart Hawthorn, Victoria and Beaufort St 24 hour Pharmacy, Perth, Western Australia.